Moving the Needle Forward in Cancer Rehabilitation

Commentary
Video

It can be hard to get exposure for a new field, but Jessica Cheng, MD, has big plans on how to advance the field of cancer rehabilitation.

When looking towards the future, Jessica Cheng, MD, hopes that patients and clinicians will underscore the importance of adding cancer rehabilitation into treatment plans as the field becomes more widespread.

She noted that with the implementation of cancer rehabilitation into treatment strategies, performance status and function can be significantly improved, which may correlate with better outcomes and reduced hospital stays. Cheng, assistant clinical professor in the Department of Supportive Care Medicine at City of Hope, wants the word to spread about this niche area, as it may allow for more informed treatment decisions and serve as an “integral part of the cancer space”.

With her catchphrase of “prehab for all”, she hopes that colleagues will learn more about cancer rehabilitation and what it can mean for their patients. By developing a greater understanding of cancer rehabilitation, practices may help patients navigate their treatment course more easily while aiding their recovery following therapy.


Transcript:

I see the value of rehabilitation medicine in the cancer space as an integral part of the cancer space. My heart’s desire is that every institution that takes care of patients with cancer will recognize the importance of optimizing function and performance status from the beginning and throughout the cancer journey from prehabilitation to rehabilitation. There’s a lot of room for growth there.

My catchphrase recently is “prehab for all”. I want everyone to be armed with this knowledge of what they can do that’s in their control to optimize their abilities for meaningful activities throughout the cancer journey. I hope that oncologists and rehabilitation physicians alike will see that there’s an opportunity with cancer prehabilitation to enable [patients] to get their cancer treatment, get through it better, and recover better. That’s my hope: that this will just spread even more like wildfire than it already is.

Recent Videos
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
Establishment of an AYA Lymphoma Consortium has facilitated a process to better understand and address gaps in knowledge for this patient group.
Adult and pediatric oncology collaboration in assessing nivolumab in advanced Hodgkin lymphoma facilitated the phase 3 SWOG S1826 findings.
Treatment paradigms differ between adult and pediatric oncologists when treating young adults with lymphoma.
Differences in pancreatic cancer responses to treatment elicits a need to better educate patients on expectations in treatment, particularly chemotherapy.
Increasing patient awareness of modifiable risk factors for pancreatic cancer may help mitigate incidence of pancreatic cancers.
It may be crucial to test every patient for markers such as BRAF V600E mutations, NRG1 fusions, and KRAS G12C mutations to help manage pancreatic cancers.